News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
839,709 Results
Type
Article (86109)
Company Profile (651)
Press Release (752949)
Section
Business (232289)
Career Advice (4125)
Deals (39705)
Drug Delivery (126)
Drug Development (90819)
Employer Resources (198)
FDA (18018)
Job Trends (17316)
News (395714)
Policy (39675)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (10)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2992)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (83)
Alliances (56686)
ALS (91)
Alzheimer's disease (1461)
Antibody-drug conjugate (ADC) (131)
Approvals (18012)
Artificial intelligence (233)
Autoimmune disease (23)
Automation (10)
Bankruptcy (403)
Best Places to Work (12564)
BIOSECURE Act (21)
Biosimilars (116)
Biotechnology (448)
Bladder cancer (60)
Brain cancer (28)
Breast cancer (235)
Cancer (1960)
Cardiovascular disease (150)
Career advice (3530)
Career pathing (33)
CAR-T (152)
Cell therapy (429)
Cervical cancer (18)
Clinical research (72866)
Collaboration (778)
Compensation (451)
Complete response letters (30)
COVID-19 (2833)
CRISPR (42)
C-suite (215)
Cystic fibrosis (98)
Data (1872)
Decentralized trials (2)
Denatured (43)
Depression (38)
Diabetes (208)
Diagnostics (6769)
Digital health (9)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (120)
Drug pricing (106)
Drug shortages (22)
Duchenne muscular dystrophy (92)
Earnings (95506)
Editorial (37)
Employer branding (25)
Employer resources (167)
Events (128440)
Executive appointments (622)
FDA (19023)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (650)
Gene editing (98)
Generative AI (23)
Gene therapy (312)
GLP-1 (751)
Government (5104)
Grass and pollen (4)
Guidances (40)
Healthcare (20775)
Huntington's disease (24)
IgA nephropathy (26)
Immunology and inflammation (125)
Indications (25)
Infectious disease (2954)
Inflammatory bowel disease (146)
Inflation Reduction Act (11)
Influenza (44)
Intellectual property (87)
Interviews (812)
IPO (17725)
IRA (47)
Job creations (5183)
Job search strategy (2861)
Kidney cancer (10)
Labor market (37)
Layoffs (534)
Leadership (21)
Legal (10072)
Liver cancer (70)
Lung cancer (291)
Lymphoma (130)
Machine learning (3)
Management (65)
Manufacturing (285)
MASH (67)
Medical device (14345)
Medtech (14350)
Mergers & acquisitions (22318)
Metabolic disorders (624)
Multiple sclerosis (73)
NASH (23)
Neurodegenerative disease (100)
Neuropsychiatric disorders (25)
Neuroscience (1975)
NextGen: Class of 2025 (7667)
Non-profit (5061)
Northern California (2262)
Now hiring (38)
Obesity (336)
Opinion (270)
Ovarian cancer (70)
Pain (79)
Pancreatic cancer (60)
Parkinson's disease (139)
Partnered (19)
Patents (204)
Patient recruitment (93)
Peanut (48)
People (64898)
Pharmaceutical (134)
Pharmacy benefit managers (17)
Phase I (22495)
Phase II (31668)
Phase III (23841)
Pipeline (1037)
Podcasts (123)
Policy (132)
Postmarket research (3544)
Preclinical (10106)
Press Release (72)
Prostate cancer (93)
Psychedelics (35)
Radiopharmaceuticals (256)
Rare diseases (381)
Real estate (7383)
Recruiting (75)
Regulatory (26501)
Reports (56)
Research institute (2646)
Resumes & cover letters (649)
Rett syndrome (2)
RNA editing (4)
RSV (33)
Schizophrenia (69)
Series A (122)
Series B (72)
Service/supplier (25)
Sickle cell disease (51)
Southern California (2005)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (33)
Startups (4283)
State (2)
Stomach cancer (11)
Supply chain (56)
Tariffs (18)
The Weekly (78)
United States (20280)
Vaccines (731)
Venture capitalists (37)
Webinars (13)
Weight loss (241)
Women's health (35)
Worklife (19)
Date
Today (78)
Last 7 days (439)
Last 30 days (2365)
Last 365 days (31962)
2025 (7991)
2024 (35396)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1269)
Alabama (55)
Alaska (6)
Arizona (241)
Arkansas (9)
Asia (49860)
Australia (8801)
California (5239)
Canada (1762)
China (480)
Colorado (187)
Connecticut (223)
Delaware (121)
Europe (114174)
Florida (718)
Georgia (158)
Hawaii (1)
Idaho (64)
Illinois (512)
India (26)
Indiana (270)
Iowa (10)
Japan (140)
Kansas (109)
Kentucky (20)
Louisiana (11)
Maine (58)
Maryland (852)
Massachusetts (4142)
Michigan (188)
Minnesota (320)
Mississippi (1)
Missouri (62)
Montana (25)
Nebraska (26)
Nevada (52)
New Hampshire (51)
New Jersey (1584)
New Mexico (29)
New York (1480)
North Carolina (1018)
North Dakota (8)
Northern California (2262)
Ohio (169)
Oklahoma (13)
Oregon (44)
Pennsylvania (1187)
Puerto Rico (11)
Rhode Island (25)
South America (1650)
South Carolina (6)
South Dakota (1)
Southern California (2005)
Tennessee (58)
Texas (732)
Utah (113)
Virginia (132)
Washington D.C. (54)
Washington State (522)
West Virginia (2)
Wisconsin (42)
839,709 Results for "sk bio pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
February 24, 2025
·
11 min read
Press Releases
SK bioscience Expands Influenza Vaccine Exports to Southern Hemisphere Market
March 12, 2025
·
3 min read
Press Releases
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
February 25, 2025
·
5 min read
Immunology and inflammation
Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
March 25, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
SK pharmteco Embarks on Journey to Achieve My Green Lab Certification, Solidifying Commitment to Sustainable Laboratory Practices
March 13, 2025
·
3 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Bluebird, Facing Cash Crunch, To Go Private In Deal Valued at $30M
The proposed acquisition by global investment firms Carlyle and SK Capital Partners could net shareholders $3 per share plus potential CVR dollars and provide bluebird bio with primary capital to expand the commercial reach of its gene therapies.
February 21, 2025
·
3 min read
·
Heather McKenzie
Press Releases
SK Life Science, Inc. to Showcase Important XCOPRI® (cenobamate tablets) CV Data on Responsive Neurostimulation Epileptiform Events at the 77th American Academy of Neurology (AAN) Annual Meeting
April 4, 2025
·
12 min read
Press Releases
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
December 13, 2024
·
5 min read
Business
Ferring Pharmaceuticals and SK Pharmteco Enter into Commercial Gene Therapy Manufacturing Deal
Ferring Pharmaceuticals and SK pharmteco today announced an agreement to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical non-replicating gene therapy ADSTILADRIN (nadofaragene firadenovec-vncg) for ensuring long-term future supply.
April 18, 2024
·
10 min read
1 of 83,971
Next
